SINGH SHARAT has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets measurement, organic fine chemistry and pharmaceuticals are PREVENTAGE HEALTHCARE LLC, C2N DIAGNOSTICS and VERAX BIOMEDICAL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Biotechnology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Unspecified technologies | |
#5 | Combinatorial chemistry | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Singh Sharat | 13 |
#2 | Liu Xinjun | 5 |
#3 | Kim Phillip | 4 |
#4 | Harvey Jeanne | 3 |
#5 | Liu Limin | 3 |
#6 | Barham Robert | 2 |
#7 | Neri Bruce | 2 |
#8 | Kirakossian Hrair | 2 |
#9 | Ybarrondo Belen | 2 |
#10 | Wang Shui Long | 2 |
Publication | Filing date | Title |
---|---|---|
US2012270745A1 | Drug selection for cancer therapy by profiling signal transduction proteins in ascites or pleural efflux samples | |
US2010022408A1 | Addressable antibody arrays and methods of use | |
US2009081711A1 | Addressable antibody arrays and methods of use | |
US2008076139A1 | Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells |